*A 3-5 minute injection time of OPDIVO Qvantig compared to 30-minute infusion time of OPDIVO. This does not account for all aspects of treatment. Does not include observation time. Actual clinic time may vary.
Actor portrayals.
OPDIVO Qvantig is a subcutaneous injection of OPDIVO that you can receive in 3-5 minutes.* A subcutaneous injection is an injection that is given under the skin. It is different from an intravenous (IV) infusion. Ask your doctor if a subcutaneous injection may be right for you.
Your injection will be given by a healthcare professional under the skin in your stomach area (abdomen) or thigh area
Treatment works with your immune system the same way whether given subcutaneously or by IV infusion
OPDIVO Qvantig was studied in a clinical trial that showed similar results and side effects to infusions of OPDIVO
In the clinical trial, 495 people who had previously treated kidney cancer and had up to two therapies that didn't work were given either OPDIVO Qvantig injections or OPDIVO IV infusions. OPDIVO Qvantig injections and OPDIVO IV infusions were compared to check that the injection works like the infusion. This was done by measuring the amount of medicine in the bloodstream after the medicines were given.
*Please note, your treatment will be given in 3-5 minutes. This refers only to the time it takes to give the injection and does not account for all aspects of treatment. Actual time at the clinic may vary.
Find out if OPDIVO Qvantig is right for you with answers to common questions people have about OPDIVO Qvantig.
OPDIVO Qvantig is an under-the-skin injection of OPDIVO and hyaluronidase. OPDIVO Qvantig includes an enzyme (hyaluronidase) which improves the way medicines are absorbed into the body when injected under the skin.
Otherwise, it still works the same way OPDIVO does with your immune system to help your body fight cancer. Another difference is that the OPDIVO Qvantig injection takes 3-5 minutes* compared to about 30 minutes for OPDIVO IV, so you will be finished with the administration faster.* Talk to your doctor to see if OPDIVO Qvantig is right for you.
It is not known if OPDIVO Qvantig is safe and effective in children. OPDIVO Qvantig may not be used in combination with ipilimumab.
*A 3-5 minute injection time of OPDIVO Qvantig compared to a 30-minute infusion time of OPDIVO. This does not account for all aspects of treatment and does not include observation time. Actual clinic time may vary.
Talk to your doctor to see if OPDIVO Qvantig is right for you; it is not known if OPDIVO Qvantig is safe and effective in children. OPDIVO Qvantig may not be used in combination with ipilimumab.
Your doctor can help you decide at any time during your treatment if you can switch to OPDIVO Qvantig from OPDIVO IV. You and your doctor can work together to decide if OPDIVO Qvantig may be right for you.
Your appointment will be similar to an OPDIVO IV appointment. Depending on decisions that you and your healthcare team have made about your treatment plan, your OPDIVO Qvantig appointment will generally have a few parts.
The time between treatments will vary from 2-4 weeks. Your healthcare team will decide the time between doses and how many treatments you will receive.
This information is not a substitute for talking to your healthcare provider because they are the best source of information about your condition.
*Please note, your treatment will be given in 3-5 minutes. This refers only to the time it takes to give the injection and does not account for all aspects of treatment. Actual time at the clinic may vary.
Learn more about the complimentary OPDIVO with You support program
Track your symptoms and other important information so that you can proactively manage potential side effects with your doctor
See which cancer types can be treated with OPDIVO Qvantig and possible side effects
Test
